These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 105616)

  • 1. Systemic vascular pooling potency of vasodilator drugs (nitroglycerin, phentolamine, hydralazine).
    Strauer BE; Scherpe A
    Am Heart J; 1979 Mar; 97(3):408-9. PubMed ID: 105616
    [No Abstract]   [Full Text] [Related]  

  • 2. Differential systemic arterial and venous actions and consequent cardiac effects of vasodilator drugs.
    Miller RR; Fennell WH; Young JB; Palomo AR; Quinones MA
    Prog Cardiovasc Dis; 1982; 24(5):353-74. PubMed ID: 6801728
    [No Abstract]   [Full Text] [Related]  

  • 3. Cardiovascular clinical pharmacology of impedance reducing agents.
    Franciosa JA; Pierpont G
    J Chronic Dis; 1981; 34(7):341-52. PubMed ID: 6788789
    [No Abstract]   [Full Text] [Related]  

  • 4. Guidelines for vasodilator therapy of congestive heart failure in infants and children.
    Artman M; Graham TP
    Am Heart J; 1987 Apr; 113(4):994-1005. PubMed ID: 3031972
    [No Abstract]   [Full Text] [Related]  

  • 5. Effects of vasodilator drugs on venous tone in conscious rats.
    D'Oyley HM; Tabrizchi R; Pang CC
    Eur J Pharmacol; 1989 Mar; 162(2):337-44. PubMed ID: 2498109
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vasodilative effect of hydralazine in awake dogs: the roles of prostaglandins and the sympathetic nervous system.
    Maekawa K; Liang CS; Tsui A; Chen BT; Kawashima S
    Circulation; 1984 Nov; 70(5):908-16. PubMed ID: 6488504
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effect of hydralazine and dihydralazine, as well as other blood pressure-lowering drugs on water uptake and excretion in rats].
    Peskar B; Leodolter S; Hertting G
    Naunyn Schmiedebergs Arch Pharmakol; 1969; 264(3):292-3. PubMed ID: 4242434
    [No Abstract]   [Full Text] [Related]  

  • 8. Afterload reduction and cardiac performance. Physiologic basis of systemic vasodilators as a new approach in treatment of congestive heart failure.
    Mason DT
    Am J Med; 1978 Jul; 65(1):106-25. PubMed ID: 99030
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of vascular tone and pulse wave velocity in human muscular conduit arteries: selective effects of nitric oxide donors to dilate muscular arteries relative to resistance vessels.
    Fok H; Jiang B; Clapp B; Chowienczyk P
    Hypertension; 2012 Nov; 60(5):1220-5. PubMed ID: 23045465
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effect of various blood pressure-lowering drugs on water uptake and output in rats].
    Peskar B; Leodolter S; Hertting G
    Naunyn Schmiedebergs Arch Pharmakol; 1970; 265(4):335-46. PubMed ID: 4244610
    [No Abstract]   [Full Text] [Related]  

  • 11. Hydralazine dilates large epicardial coronary arteries in conscious dogs through an endothelium-independent mechanism.
    Drieu la Rochelle C; Dubois-Randé JL; Hittinger L; Richard V; Berdeaux A; Giudicelli JF
    J Cardiovasc Pharmacol; 1994 Feb; 23(2):315-8. PubMed ID: 7511763
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of hydralazine on the development of tolerance to continuous nitroglycerin.
    Parker JD; Parker AB; Farrell B; Parker JO
    J Pharmacol Exp Ther; 1997 Feb; 280(2):866-75. PubMed ID: 9023301
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of hydralazine, nitroglycerin, and food on estimated hepatic blood flow.
    Svensson CK; Cumella JC; Tronolone M; Middleton E; Lalka D
    Clin Pharmacol Ther; 1985 Apr; 37(4):464-8. PubMed ID: 3919988
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of reserpine pretreatment on in vivo femoral arterial responses to vasodilator agents.
    Cauvin CA; Devia CJ; Kirkendol PL
    J Pharmacol Exp Ther; 1981 Mar; 216(3):447-52. PubMed ID: 6782236
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of vasodilators on the signal intensity of perfluorocarbon monitored by in vivo 19F-NMR spectroscopy.
    Sogabe T; Imaizumi T; Mori T; Tominaga M; Koga K; Yabuuchi Y
    Magn Reson Imaging; 1997; 15(3):341-5. PubMed ID: 9201682
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of vasodilators at rest and during exercise in young adults with cystic fibrosis and chronic cor pulmonale.
    Geggel RL; Dozor AJ; Fyler DC; Reid LM
    Am Rev Respir Dis; 1985 Apr; 131(4):531-6. PubMed ID: 3994148
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Vasodilator agents in the treatment of cardiac insufficiency].
    Bertel O
    Ther Umsch; 1984 Feb; 41(2):117-24. PubMed ID: 6424258
    [No Abstract]   [Full Text] [Related]  

  • 18. Platelet behaviour and drugs used in cardiovascular disease.
    Hampton JR; Harrison MJ; Honour AJ; Mitchell JR
    Cardiovasc Res; 1967 Apr; 1(2):101-7. PubMed ID: 4964626
    [No Abstract]   [Full Text] [Related]  

  • 19. Contrasting acute effects of vasodilators (nitroglycerin, nitroprusside, and hydralazine) on right ventricular performance in patients with chronic obstructive pulmonary disease and pulmonary hypertension: a combined radionuclide-hemodynamic study.
    Brent BN; Berger HJ; Matthay RA; Mahler D; Pytlik L; Zaret BL
    Am J Cardiol; 1983 Jun; 51(10):1682-9. PubMed ID: 6407295
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pressure pulse contour analysis in determining the effect of vasodilator drugs on vascular hemodynamic impedance characteristics in dogs.
    Zobel LR; Finkelstein SM; Carlyle PF; Cohn JN
    Am Heart J; 1980 Jul; 100(1):81-8. PubMed ID: 6770667
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.